Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
87.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (5.882%)
Market Cap: £5.75m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Technology provider for study on ageing

7 Apr 2010 07:00

RNS Number : 7582J
Crimson Tide PLC
07 April 2010
 



Crimson Tide Plc

("Crimson Tide" or the "Company")

CRIMSON TIDE TECHNOLOGY KEEPS IRISH GOVERNMENT PROJECT SECURE

Crimson Tide, the mobile software technologies company, is pleased to announce that a ten year study initiated by the Irish Government to ensure that the needs of its older people are met, is utilising an advanced mobile system developed by the Company to guarantee security and confidentiality.

 TILDA (The Irish LongituDinal Study on Ageing) was launched by Minister for Health Mary Harney in November 2006, to study a representative sample of at least 8,000 people, aged 50 years and over and resident in Ireland. It charts their health, social and economic circumstances over a 10-year period.

The study is being carried out across the whole of Ireland by Trinity College Dublin in collaboration with a panel of scientific researchers and international scientists with expertise in various fields of ageing. Crimson Tide's system ensures this operation is carried out in a secure and confidential manner using mobile portable technology. 

The application is centred around the Motorola MC55 hand held device and requires the user to identify and capture each respondent's details. It enables the user to move through a series of screens, adding additional data relevant to the project, as they proceed. 

 The system uses real time GPRS data transfer to ensure that records are updated immediately after each visit, and the hand held device interacts with a number of application-based tests carried out on a laptop computer. All information gathered is kept strictly confidential and used only for research purposes.

Says Dr Hilary Cronin, Medical Director for TILDA: "Crimson Tide is an exceptional company to work with and I cannot recommend them highly enough. Their people are incredibly efficient and so pleasant to deal with. They spent time ensuring that our technology interfaces were user friendly and intuitive. Our initially 'techno-phobic' research nurses now love their PDA's and can't imagine collecting data without them! It has significantly improved the way we conduct our clinical research. Their technologies are now an integral part of our study and I look forward to working with them again in the future."

Crimson Tide Director Laurence Darcy says: "It has been a privilege to work on this study with Trinity College Dublin to develop a state-of-the art mobile data solution. We are working on a range of solutions in the healthcare sector and expect to have more innovative solutions coming to the market this year."

- ends -

For further information, contact:

Crimson Tide plc

Barrie Whipp, Executive Chairman

 

01892 542 444

Threadneedle Communications

Graham Herring/Josh Royston

 

020 7653 9850

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAXQLFBBZFXBBD
Date   Source Headline
30th Jun 202011:53 amRNSResult of AGM and Trading Update
15th Jun 202010:42 amRNSSignificant Contract Win
9th Jun 20204:06 pmRNSAnnual Report and Notice of AGM
7th May 20207:11 amRNSPreliminary Results
4th May 20204:05 pmRNSDIRECTOR RESIGNATION
1st Apr 20203:30 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSStatement regarding Coronavirus
13th Mar 20207:00 amRNSChange of Adviser
25th Feb 20208:19 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSSignificant contract wins in the rail sector
28th Jan 202010:43 amRNSHolding(s) in Company
3rd Jan 20209:17 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSSignificant long-term contract and trading update
1st Oct 20197:00 amRNSSignificant long-term contract win
27th Sep 20197:00 amRNSInterim Results
1st Jul 20197:00 amRNSDirector and Company Secretary Appointment
28th Jun 20193:02 pmRNSResult of AGM
27th Jun 20197:00 amRNSContract Wins and New Partnerships
7th Jun 20197:00 amRNSFinal Results and Notice of AGM
17th May 20197:00 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSPreliminary Announcement of Results to 31/12/18
16th Apr 20199:20 amRNSHolding(s) in Company
1st Mar 20192:56 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSContract Wins in the rail sector
29th Jan 20197:00 amRNSTrading Update
2nd Nov 20182:08 pmRNSExercise Of Options
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.